drugset / Trial / NCT02034799
Phase IV Bioseal Study in Brain Tumor Surgery
RandomizedParallel-groupSingle-blindTreatment
Summary
The objective of this study is to observe the clinical utility and performance of Bioseal when used as an adjunct to hemostasis versus Standard of Care (SoC) in elective meningioma surgery.
Timeline
- Start
- 2013-11-01
- Primary completion
- 2014-08-01
- Completion
- 2014-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bioseal Fibrin Sealant | Protein / enzyme biologic | — | — |